Literature DB >> 20571731

Use and utility of a 24-hour Telephone Support Service for 'high risk' patients with COPD.

John R Hurst1, Fiona Fitzgerald-Khan, Jennifer K Quint, James Jp Goldring, Christine Mikelsons, J Paul Dilworth, Jadwiga A Wedzicha.   

Abstract

BACKGROUND: Hospitalisations are important events in COPD, and exacerbation prevention strategies are not completely effective. Experience with our research cohort suggested that availability of 24-hour telephone advice may reduce hospital admission. AIM: To examine the use and utility of a 24-hour Telephone Support Service for high-risk NHS COPD patients.
METHOD: 74 patients with 'high-risk' COPD had therapy optimised, were educated about exacerbations, given home 'emergency' therapy, and had 24-hour access to telephone advice.
RESULTS: Patients had a mean (SD) age of 70.4 (9.1) years and severe disease (mean FEV1 1.00 (0.37) litre; 30% had home oxygen and 46% lived alone). There were 258 telephone calls in 22,074 follow-up days. 76% of calls were received between 0800 and 1700 hours. The proportion of possible exacerbation ('appropriate') calls (overall 56%) was higher at weekends and overnight. Overnight calls (2100- 0800) were rare: to expect one appropriate call per shift would require 2453 patients. A third of appropriate overnight calls could be managed without further emergency assessment. Mean (SD) length of follow-up was 298 (117) days/patient. Patients completing one year of follow-up (n=52) demonstrated a 45% reduction in admissions and 37% reduction in bed days. Patient satisfaction was high.
CONCLUSIONS: We report data on the use and utility of a 24-hour Telephone Support Service in COPD. The service was associated with a reduction in hospital admission. Call volume was low, thus giving information on the size and cost-effectiveness of such service provision.

Entities:  

Mesh:

Year:  2010        PMID: 20571731      PMCID: PMC6602239          DOI: 10.4104/pcrj.2010.00035

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  5 in total

Review 1.  Home telehealth for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis.

Authors:  J Franek
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

2.  Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.

Authors:  Barbara P Yawn; Byron Thomashow
Journal:  Int J Gen Med       Date:  2011-09-12

3.  The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations.

Authors:  Bernardino Alcazar; Pilar de Lucas; Joan B Soriano; Alonso Fernández-Nistal; Antonia Fuster; Jose Miguel Rodríguez González-Moro; Aurelio Arnedillo; Patricia García Sidro; María José Espinosa de Los Monteros
Journal:  BMC Pulm Med       Date:  2016-11-08       Impact factor: 3.317

4.  24-hour access outpatient clinic for patients with exacerbation of chronic disease: a before-after cohort study of differences in acute healthcare utilisation.

Authors:  Anders Damgaard Møller; David Høyrup Christiansen; Cathrine Bell; Ulrich Fredberg; Peter Vedsted
Journal:  BMC Health Serv Res       Date:  2018-08-28       Impact factor: 2.655

5.  Out-of-clinic patient communication in paediatric rheumatology: the extent and nature of demand.

Authors:  Debi V Feldman; Jo Buckle; Jane E Munro; Roger C Allen; Jonathan D Akikusa
Journal:  Pediatr Rheumatol Online J       Date:  2013-03-27       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.